{"entity":{"id":"nct02171221","kind":"trial","name":"Phase I Study of Oral DFP-11207 in Solid Tumors","aka":[],"tldr":"A phase 1 trial of DFP-11207 run by Delta-Fly Pharma, Inc., completed.","summary":"Phase I Study of Oral DFP-11207 in Solid Tumors is a phase 1 interventional study registered as NCT02171221 by Delta-Fly Pharma, Inc., with 23 participants enrolled, started 2014-06. Conditions recorded: Solid Tumors and Cancer. Interventions recorded: Oral DFP-11207.","status":"completed","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT02171221","url":"https://clinicaltrials.gov/study/NCT02171221"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["dfp-11207"],"companies":["delta-fly-pharma"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT02171221","phase":"1","setting":"A Phase I Study of Once-Daily Oral DFP-11207 in Patients With Solid Tumors","sponsor":"Delta-Fly Pharma, Inc.","enrolled":23,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct02171221/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"drug":[{"id":"dfp-11207","kind":"drug","name":"DFP-11207","route":"/drugs/dfp-11207/"}],"company":[{"id":"delta-fly-pharma","kind":"company","name":"Delta-Fly Pharma","route":"/companies/delta-fly-pharma/"}]}}